Q100 Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Q100 Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2020-12-05 Hyderabad, Telangana Active Unlisted
Share
Connect MCP
QL Q100 Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Q100 Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Q100 Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 75/100. Q100 Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 17 Aug 2026 from the latest processed filings. Q100 Life Sciences Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
JANARDHAN 01234567 Director 01/04/2018 6 yrs Approved
RAGHUNATHAREDDY PULIM 01234567 Director 01/04/2018 6 yrs Approved
DHARMA TEJ REDDY 01234567 Director 01/04/2018 6 yrs Approved
RAKESH KOLLI 01234567 Director 01/04/2018 6 yrs Approved
BONTHU KUMARI ARUNA 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • JANARDHAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 65
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Net margin improved to 2.1x.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 24% in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment69/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
28 Apr 2025
Director appointed
BONTHU KUMARI ARUNA (Additional Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
18 Jan 2024
Director appointed
RAKESH KOLLI (Additional Director)
Director ceased
VEMULA NAGESWARA RAO
22 Nov 2023
Director ceased
VENKATA DHARMA TEJ REDDY PULIM
12 Nov 2022
Director ceased
JANARDHAN
Director ceased
RAGHUNATHAREDDY PULIM
24 Nov 2021
Director appointed
JANARDHAN (Additional Director)
Director appointed
RAGHUNATHAREDDY PULIM (Additional Director)
05 Dec 2020
Incorporated
Registered with Roc Hyderabad
Director appointed
DHARMA TEJ REDDY (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 1 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Datarola Computer Systems Private Limited U72200KL1995PTC009816 Ernakulam, Kerala, India
Autopartshub U50103TG2015PTC100106 Secunderabad, Telangana, India
Bright Bakers India Private Limited U15134RJ2020PTC068878 Jaipur, Rajasthan, India
Om Girjapati Automobiles Private Limited U50400UP2022PTC167521 Atrauli, Uttar Pradesh, India
Apexo Packing Machine Private Limited U29309DL2018PTC338079 New Delhi, Delhi, India
Pine Polymers Private Limited U51101DL1996PTC077930 Delhi, Delhi, India
Lucky Gold Star Company Private Ltd U27205WB1985PTC038901 Kolkata, West Bengal, India
Super Parts Pvt. Ltd U74899DL1978PTC009097 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Q100 Life Sciences Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Q100 Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Q100 Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Q100 Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Q100 Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Q100 Life Sciences Private Limited an active company?

Q100 Life Sciences Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Q100 Life Sciences Private Limited financially healthy?

Q100 Life Sciences Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Q100 Life Sciences Private Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Q100 Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Q100 Life Sciences Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Q100 Life Sciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Q100 Life Sciences Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.